Piper Sandler Adjusts Price Target on Hims & Hers Health to $18 From $16, Maintains Neutral Rating
Stoke Therapeutics Analyst Ratings
Alpha & Omega Analyst Ratings
WD-40 Analyst Ratings
BofA Securities Adjusts Price Target on Boise Cascade to $123 From $129
Susquehanna Cuts Price Target on Noble to $47 From $49, Maintains Neutral Rating
Stoke Therapeutics (STOK) Receives a Buy From Wedbush
Stifel Nicolaus Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)
Citi Cuts Lamar Advertising to Neutral on Limited Share Upside
Alphatec Holdings Analyst Ratings
AZZ (AZZ) Receives a Buy From Noble Financial
Analysts Have Conflicting Sentiments on These Healthcare Companies: Unicycive Therapeutics (UNCY), LifeMD (LFMD) and Teladoc (TDOC)
Craig-Hallum Reaffirms Their Buy Rating on Aspen Aerogels (ASPN)
Chart Industries (GTLS) Gets a Buy From Craig-Hallum
Craig-Hallum Sticks to Its Buy Rating for Full House Resorts (FLL)
Blue Bird (BLBD) Receives a Buy From Craig-Hallum
Craig-Hallum Sticks to Their Buy Rating for Vita Coco Company (COCO)
Lake Street Sticks to Their Buy Rating for SunOpta (STKL)
Analyst Ratings For Abercrombie & Fitch
Ribbon Receives Buy Rating by Rosenblatt Despite Sub-$5 Stock Status